National Pharmaceutical Congress (NPC) Podcast

Auteur(s): Chronicle Companies
Écouter gratuitement

  • Résumé

  • Created in response to industry requests, NPC Podcast hosts Jim Shea, Mark McElwain and Mitch Shannon interview an esteemed series of guests with pertinent questions about the pharma industry.

    healthbiz.substack.com
    Chronicle Information Resources Ltd.
    Voir plus Voir moins
Sciences biologiques
Voir plus Voir moins
activate_Holiday_promo_in_buybox_DT_T2
Épisodes
  • S13 E04 Eli Lilly’s Focus on Innovative Therapeutics

    S13 E04 Eli Lilly’s Focus on Innovative Therapeutics
    Nov 20 2024

    Kenneth Custer, President and General Manager of Eli Lilly Canada, gives insights into his background in neuroscience, innovation in healthcare, and progress in therapeutics for obesity and Alzheimer’s.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    Voir plus Voir moins
    24 min
  • S13 E03 Innovating Rare Disease Research

    S13 E03 Innovating Rare Disease Research
    Oct 30 2024

    Jonathan Soong, General Manager of Amicus Therapeutics, gives insights into being at the forefront of rare disease innovations, patient support programs, and the importance of real world evidence for rare diseases.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    Voir plus Voir moins
    25 min
  • S13 E02 Rodrigo Reis of UCB Pharma on Innovation in Pharma

    S13 E02 Rodrigo Reis of UCB Pharma on Innovation in Pharma
    Oct 16 2024

    Rodrigo Reis, General Manager of UCB Pharma Canada, gives insights into fostering innovation in pharma, collaborating with UHN to expedite diagnoses, and entering the rare disease space with new innovative therapeutics.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    Voir plus Voir moins
    29 min

Ce que les auditeurs disent de National Pharmaceutical Congress (NPC) Podcast

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.